St. Jude Medical (NYSE:STJ) and Boston Scientific (NYSE:BSX) are touting new developments in Europe for their spinal cord stimulation systems. St. Paul, Minn.-based St. Jude said it won CE Mark approval in the European Union for its Invisible Trial app-based wireless neuromodulation system, the company said. The system leverages Apple (NSDQ:AAPL) iOS devices, specifically an iPod touch for […]
Spine
Medtronic settles IRS beef for $330m
Medtronic (NYSE:MDT) took a nearly $330 million charge during its fiscal 4th quarter to cover a tax settlement with the IRS over its $4.2 billion acquisition of Kyphon in 2007. CFO Gary Ellis, during a conference call yesterday discussing the company’s Q4 results, said the dispute concerned the $3.3 billion in overseas cash Medtronic used to […]
VertiFlex wins FDA nod for Superion spine device
VertiFlex said today that it won pre-market approval from the FDA for its Superion interspinous spacer for treating moderate lumbar spinal stenosis.
NuVasive names Lucier CEO
NuVasive Inc. (NSDQ:NUVA) said today that it promoted its interim chief executive to the full-time spot, naming chairman Gregory Lucier CEO.
St. Jude launches Prodigy spinal cord stimulator in Canada
InVivo reports mixed results in spinal scaffold trial
Medtronic launches new spine devices
NuVasive gains on Q1 results, new platform launch
NuVasive Inc. (NSDQ:NUVA) shares are up today on a 1st-quarter swing to black ink and the launch of its 1st major new platform in a decade.
Globus: Witness for J&J’s Synthes faked credentials
Appeals court declines Medtronic’s review bid in NuVasive spat
Medtronic gets in on $10m Series C for Ortho Kinematics
Ortho Kinematics said yesterday that it drummed up a $9.6 million Series C round for its vertebral motion analysis technology, its flagship product.